Home
Conditions
Neurotoxicity Syndromes

Clinical trial condition

Neurotoxicity Syndromes

Explore clinical trials studying Neurotoxicity Syndromes. Study availability and eligibility vary by location and protocol.

93 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Neurotoxicity Syndromes trial results

Enrolling by Invitation

Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in Infancy

NCT05911139

Conditions: Anesthesia, Bone Diseases, Bone Diseases, Developmental, +14 more
Locations: Department of paediatric anaesthesiology and intensive medicine Bratislava, Slovakia

View Trial Details

Not Yet Recruiting

Delayed Toxicities Post-CAR-T

NCT07665307

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: UCSF Medical Center San Francisco, California, United States

Mount Sinai New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Not Yet Recruiting

Assessing DCog Short for Neurotoxicity in CAR-T

NCT07403812

Conditions: Chemically-Induced Disorders, Hematologic Diseases, Hematologic Malignancy, +9 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

NCT01445288

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy

NCT05025826

Conditions: Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Centre Hospitalier de Cholet Cholet, France

Clermont-Ferrand UH Clermont-Ferrand, France

Chd La Roche Sur Yon La Roche-sur-Yon, France

Hôpital le Confluent Nantes, France

View Trial Details

Completed

Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors

NCT03628300

Conditions: Acute Kidney Injury, Beta Lactams, Chemically-Induced Disorders, +19 more
Locations: CHU Amiens-Picardie Amiens, France

View Trial Details

Completed

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

NCT07333976

Conditions: Chemically-Induced Disorders, Chemotherapy Induced Peripheral Neuropathy (CIPN), Nervous System Diseases, +6 more
Locations: Tri-Service General Hospital Taipei, Neihu, Taiwan

View Trial Details

Completed

Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients

NCT07320950

Conditions: Chemically-Induced Disorders, Colonic Diseases, Colorectal Cancer, +13 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

NCT04150913

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity

NCT00727922

Conditions: Cancer, Chemically-Induced Disorders, Neoplasms, +4 more
Locations: Cochin Paris, France

View Trial Details

Neurotoxicity Syndromes

Neurotoxicity Syndromes trial results

Related conditions